CD8A and neoplasm: It has been postulated that T-lymphocyte-mediated cross reactivity with predominant intrafollicular infiltrates of CD8+ against antigens shared between tumor cells and melanocytes on previously immune privileged area on the hair follicle may be an indicator of response in patients treated with therapy by ICI.